Epilepsy

Latest News

May 20th 2019

FDA OKs Midazolam Nasal Spray for Treating Intermittent Epileptic Seizures

Midazolam (Nayzilam) is indicated for seizures that are distinct from a patient's usual seizure pattern, in individuals age 12 years and older with epilepsy.

May 20th 2019

FDA Approves Nasal Spray for Certain Seizures in Patients with Epilepsy

May 2nd 2019

Multiple Sclerosis Drug Treatment May Be Effective for Epilepsy

By Jennifer Nessel, Assistant Editor

Epilepsy

Latest News

Trending on Pharmacy Times

Understanding Kratom: Pharmacology, Safety, and Regulation

GLP-1s and Obesity Care: Cardiorenal Outcomes, Prescribing Considerations, and Access Barriers

GLP-1 Receptor Agonists and Cancer: Considerations for Specialty Pharmacists

How Stanford Pharmacists Help Close Heart Failure Therapy Gaps

Who Should Track Gene Therapy Outcomes Long Term? ASTCT Panel Debates Shared Responsibility